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PURPOSE. To identify causal gene mutations in 14 families with autosomal dominant (AD) high
myopia using exome sequencing.
METHODS. Select individuals from 14 large Caucasian families with high myopia were exome
sequenced. Gene variants were filtered to identify potential pathogenic changes. Sanger
sequencing was used to confirm variants in original DNA, and to test for disease cosegregation
in additional family members. Candidate genes and chromosomal loci previously associated
with myopic refractive error and its endophenotypes were comprehensively screened.
RESULTS. In 14 high myopia families, we identified 73 rare and 31 novel gene variants as
candidates for pathogenicity. In seven of these families, two of the novel and eight of the rare
variants were within known myopia loci. A total of 104 heterozygous nonsynonymous rare
variants in 104 genes were identified in 10 out of 14 probands. Each variant cosegregated with
affection status. No rare variants were identified in genes known to cause myopia or in genes
closest to published genome-wide association study association signals for refractive error or
its endophenotypes.
CONCLUSIONS. Whole exome sequencing was performed to determine gene variants implicated
in the pathogenesis of AD high myopia. This study provides new genes for consideration in
the pathogenesis of high myopia, and may aid in the development of genetic profiling of those
at greatest risk for attendant ocular morbidities of this disorder.
Keywords: high myopia, candidate genes, variants, exome sequencing, GWAS
Myopic refractive error, also known as short-sightedness, isthe most common eye disorder worldwide. The extreme
form, high myopia, is defined as a refractive error of 6.00
diopters (D) or higher. High myopia affects 2% to 5% of
Americans, Western Europeans, and Australians aged older than
40 years.1 In East Asian countries, the prevalence of high
myopia has been reported as low as 1.8% to 5% in Chinese
adults aged older than 30 years,2,3 while higher rates are seen in
Singaporean children aged 7 to 9 years (14.6%–17.9%)4 and
university students in Taiwan (up to 38%).5
High myopia is characterized by axial elongation and
thinning of the sclera,6,7 with predisposition to additional
ocular morbidities such as retinal detachment, glaucoma, and
premature cataracts.1,3,8 Recently, exome sequencing of large
families with high myopia has identified mutations in the genes
LEPREL1/P3H2 and SCO2.9,10 The disease caused by mutations
in LEPREL1/P3H2 followed an autosomal recessive inheritance
pattern.9,11 Genome-wide association studies (GWAS) have
identified over 60 candidate genes associated with refractive
error.12,13 Familial linkage studies have also mapped 23 myopia
(MYP) loci associated with high myopia. Significant linkage was
first reported in eight families with autosomal dominant (AD)
high myopia on chromosome 18p11.31.14,15 Since then,
additional loci have been mapped on several chromosomes
(Table 1). Known myopia genes, myopia-associated genes
identified by GWAS, and MYP chromosomal regions have been
extensively reviewed.38–40
Recently, Holden et al.41 estimated an increase in the
prevalence of high myopia (greater than 5.00 D) from 163
million people (2.7% global population) in 2000 to 938 million
people (9.8% global population) by 2050. This estimation
utilized published data from 145 studies since 1995, covering
2.1 million participants. Vitale et al.42 also noted an 8-fold
increase in high myopia (greater than 7.9 D) in the United
States over a 30-year period from 1971 to 1972 to 1999 to
2004.42 Increased prevalence of myopia was observed regard-
less of age, race, sex, severity of the phenotype, or years of
formal education. While the prevalence of high myopia may be
increasing worldwide, the condition is still relatively uncom-
mon with many unanswered questions. Increased availability of
formal education and decreased exposure to rural or outdoor
environments, compared to earlier decades, may partially
account for an earlier onset of a myopic phenotype when
combined with genetic susceptibility. Genetic analysis of high
myopia within families such as those presented in this study
may provide further insight into the intersecting contributions
of biology with environment.
In this study, we sought to identify causal gene mutations in
our high myopia cohort by examining known myopia genes,
susceptibility loci identified through published GWAS data and
chromosomal regions within the reported MYP loci coordi-
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nates. Selected members from 14 nonsyndromic high myopia
families underwent exome sequencing. As each family
pedigree appeared to demonstrate AD inheritance transmis-
sion, it was hypothesized that each family would carry a single
heterozygous private/rare mutation that caused the disease. We
also employed a filtering strategy to identify additional rare and
conserved variants, thereby expanding the list of candidate
genes associated with high myopia. Determining causative
genetic and therefore biologic factors for high myopia
development will inform more effective strategies to reduce
or minimize the likelihood of developing blindness due to
associated ocular risks, and improve quality of life for those
affected.
MATERIALS AND METHODS
Human Subjects
We recruited 14 families with high myopia when DNA could be
obtained from at least three living affected relatives (Supple-
mentary Figs. S1–S14). Informed consent was obtained from all
participants, with approval by the Institutional Review Board
at the University of Wisconsin (Madison, WI, USA) according to
the tenets of the Declaration of Helsinki. Spherical equivalent
(SE) refractive error measurements were conducted and DNA
was extracted from blood and/or saliva from participating
family members. In our study, 8 of the 14 families were from
Denmark, 4 families were from the United States, 1 family was
of English/Canadian descent, and 1 family was of Hawaiian/
Chinese descent. The families ranged in size from three
individuals with high myopia up to the largest family (family
56) with 14 affected individuals. Ethnicity, SE refractive error
ranges, and affection status information for each family is
available in Table 2.
The affected high myopia phenotype was determined to be
those with SE refractive error greater than6.00 D. Unaffected
persons were defined by having SE refractive error less than
2.00 D. Those refractive errors reported by hearsay are
indicated in gray in the pedigree figures. They represent
primarily deceased and older generations who were not
genotyped in this study: family 8, II:1, II:3, family 56, II:1,
II:3, III:13, family 104, I:1, family 126 I:1, II:2, IV:7, and family
130, I:1.
Refractive errors were self-reported for the following
patients: family 104, individual I:1 (high myopia in both eyes,
cataract removed without intraocular lens placement in the left
eye to mitigate myopia); and family 111, individuals I:2, II:1,
II:2 (refractive errors obtained prior to LASIK corneal surgery
to mitigate their myopia). These individuals were genotyped in
this study.
To the best of our knowledge, none of the subjects used in
this study presented with systemic disorders associated with
myopia, including Marfan syndrome, Ehlers-Danlos syndrome,
Stickler syndrome, or Wagner syndrome. Affected subjects had
no other known ocular disorders or abnormalities, apart from
family 101 where some affected family members developed
glaucoma later in life. Individuals with SE refractive errors
between 2.00 D and 6.00 D were excluded from the study,
as they could not be considered neither affected nor
unaffected. We sought to perform an extreme phenotype
genotyping screening approach for this quantitative trait.
Exome Sequencing
Exome sequencing of pedigrees selected for this study were
performed at three facilities. Samples sequenced by the
Hudson Alpha Institute for Biotechnology (Huntsville, AL,
USA) used a commercial capture kit (SeqCap EZ Exome
Capture Kit v2 and v3 and 2 3 100 bp, paired-end; Roche
NimbleGen, Inc., Madison, WI, USA) reads on a sequencing
platform (HiSeq2000; Illumina, Inc., San Diego, CA, USA).
Samples sequenced by the Center for Human Genome
Variation at Duke University (Durham, NC, USA) used a
commercial capture kit (Roche NimbleGen, Inc.) and a
sequencing platform (HiSeq2000 or HiSeq2500; Illumina,
Inc.). Sequences were aligned to the GRCh37/hg19 human
genome assembly using Burrows Wheeler Aligner (BWA) and
variants called using the Genome Analysis Toolkit (GATK).
Samples sequenced by the University of Wisconsin Biotech-
nology Center DNA Sequencing Facility (Madison, WI, USA)
used a commercial kit (Sure Select Exome v5 and 23 100 bp,
paired-end; Agilent Technologies, Inc., Santa Clara, CA, USA)
TABLE 1. Chromosomal Regions Associated With Myopia
Locus
Chromosomal
Location Reference
MYP1 Xq28 Ratnamala et al.16
MYP2 18p11.31 Young et al.14; Young et al.15
MYP3 12q21-q23 Young et al.17
MYP5 17q21–q22 Paluru et al.18
MYP6 22q12 Stambolian et al.19; Klein et al.20
MYP7 11p13 Hammond et al.21
MYP8 3q26 Hammond et al.21
MYP9 4q12 Hammond et al.21
MYP10 8p23 Hammond et al.21
MYP11 4q22-q27 Zhang et al.22
MYP12 2q37.1 Paluru et al.23
MYP13 Xq23-q27.2 Zhang et al.24; Zhang et al.25
MYP14 1p36 Wojciechowski et al.26
MYP15 10q21.1 Nallasamy et al.27
MYP16 5p15.33-p15.2 Lam et al.28
MYP17/MYP4 7p15 Paget et al.29; Ciner et al.30
MYP18 14q22.1-q24.2 Yang et al.31
MYP19 5p15.1-p13.3 Ma et al.32
MYP20 13q12.12 Shi et al.33
MYP21 1p22.2 Shi et al.34
MYP22 4q35 Zhao et al.35
MYP23 4p16.3 Aldahmesh et al.36
MYP24 12q13 Guo et al.37
TABLE 2. Clinical Data From 14 Families Affected With High Myopia
Family Ethnicity
Ascertained
Affected
Individuals, n
SE Range,
D
SE Median,
D
8 Hawaiian/Chinese 7 3.75*/12.25 7.875
19 Caucasian (US) 3 6.875/19.50 17.438
56 Caucasian (US) 14 7.25/27.00 14.625
68 Caucasian (English/
Canadian)
7 6.00/50.00 7.75
81 Caucasian (US) 4 4.75*/24.75 18.00
101 Danish 5 8.75/17.00 15.00
104† Danish 3 9.75/17.00 13.875
110† Danish 5 5.25*/16.00 11.25
111† Danish 3 9.00/10.50 10.00
115 Danish 3 6.00/11.50 10.00
122 Danish 3 5.75*/9.00 7.25
126 Danish 9 6.50/19.50 10.625
130 Danish 4 7.00/10.75 8.375
155 Caucasian (U.S.) 4 13.75/19.25 17.50
* SE lower than 6.00 D reported in one eye.
† Some refractions in this family are self-reported by patients.
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reads on a sequencing platform (Illumina, Inc.). University of
Wisconsin Biotechnology Center analysis of DNA sequencing
data was performed as follows: Adapter sequences and low-
quality sequencing reads were trimmed using Skewer.43 We
used BWA-maximal exact matches (MEM) to align all reads to
the reference genome, GRCh37/hg19 assembly.44 Duplicate
alignments were then removed using Picard (http://picard.
sourceforge.net, in the public domain). Finally, variants were
called using GATK HaplotypeCaller version 3.3 and annotated
with SNPeff.45,46
Variant Analysis
Single nucleotide polymorphisms (SNPs) and insertion/dele-
tion (indel) changes were filtered and analyzed using SNP and
Variation Suite Software v8.3 (Golden Helix, Bozeman,
Montana). Variant filtering included the following steps (Fig.):
1. Excluded variants outside of exonic and splice-site
regions (within 2 bp; RefSeq Genes 105v2, NCBI);
2. Excluded synonymous variants;
FIGURE. Overview of the variant filtering strategy of exome sequencing data.
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3. Excluded variants with global minor allele frequencies
(MAF) greater than 0.001 in the Exome Aggregation
Consortium (ExAC) database (ExAC Variant Frequencies
0.3 BROAD)47;
4. With the exception of indels, excluded variants with
negative conservation level across vertebrate species
(PhyloP 100-way vertebrate score less than zero)48;
5. Excluded variants that were not heterozygous in all
affected individuals within each family;
6. Excluded variants present in unaffected individuals
within the corresponding family, confirmed variant
present in raw sequence alignment data, and excluded
variants observed in the ExAC database with a MAF
greater than 0.001 in any ethnicity.
Additionally, a filtering track was created for use in the Golden
Helix software to retrieve all gene variants contained within the
23 MYP chromosomal regions (discussed in OMIM 160700).49
Confirmation of variants that were novel or located within MYP
loci was performed by Sanger sequencing. Cosegregation
analysis was also performed when additional family members
were available for screening. Primers used for screening SCO2
were as follows: 5 0-GCTTGTTTCCAGGAGCATCA-3 0and 5 0-
TGGCTCAAGACAGGACACT-30.
RESULTS
After filtering of the exome data, a total of 104 heterozygous
variants in 104 genes were identified in 10 families with
nonsyndromic high myopia. Variants meeting our filtering
criteria were not identified in four families. Each variant
identified was located within the coding region or splice site of
the gene, reported at a frequency of less than 1 in 1000 alleles
in any population in the Exome Aggregation Consortium
(ExAC) database, and present in all relevant individuals with
high myopia in each family that were available for screening.
None of the variants were identified in unaffected family
members (SE refractive error of 2.00 D or less severe) or
individuals that married into the family. Ten variants were
identified within myopia-associated (MYP) chromosomal re-
gions (Table 3). We found 31 of the 104 variants identified
were novel changes unreported in genetic population databas-
es (Table 4). Two variants were both novel and located within
MYP loci. In our cohort, 73 variants identified were
uncommon (less than 1 in 1000 alleles in any population;
Supplementary Table S2). Confirmation of the 31 novel
variants and 8 rare variants located within MYP loci was
achieved by Sanger sequencing.
DISCUSSION
In this study, exome sequencing was utilized to identify gene
variants in individuals affected with nonsyndromic high
myopia. The association of high myopia and specific genes,
chromosomal loci, and SNPs has been previously investigated
and reported in several studies. For this analysis, we sought to
examine these associations within our own high myopia
cohort. We did not observe more than one variant in the same
gene in more than one family, and hypothesized that each
family harbors its own private pathogenic mutation resulting in
high myopia. Since high myopia is a rare disease (2%–5% in the
global population),1 we hypothesized that a causal variant that
segregates with high myopia should also be rare. We also
examined variants that were novel or observed in less than 1 in
1000 alleles in ~61,000 individuals represented in the ExAC
database. We identified potentially pathogenic heterozygous T
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variants in 10 families with high myopia that followed the
autosomal dominant inheritance pattern.
A premature stop codon variant (p.Gln53*) in SCO2 was
previously reported in a family with autosomal dominant high
myopia.10 The gene SCO2 encodes a protein involved in
mitochondrial cytochrome c oxidase activity and maps to
chromosome 22q13.33, which is located within the MYP6
locus (OMIM 608908).49 A link between cytochrome c oxidase
deficiency and refractive error has not been demonstrated.
Tran-Viet et al.10 also reported three additional SCO2 mutations
in three highly myopic unrelated individuals: p.Arg114His,
p.Glu140Lys, and p.Ala259Val. The highest frequencies of each
of these genetic variants are reported in the ExAC database at
0.2343% (Latino); 0.01812% (non-Finnish European); and
3.26% (African), respectively. A recent study examined 35
human subjects carrying the p.Glu140Lys mutation, as well as
mice carrying heterozygous, compound heterozygous, or
homozygous Sco2 mutations.50 None of the individuals
carrying SCO2 mutations that were examined demonstrated
high myopia (SE refractive error greater than6.00 D), with no
significant differences in refraction found between three
p.Glu140Lys carriers and two healthy individuals in the same
family. Furthermore, adult Sco2-deficient mice revealed no
axial elongation indicative of high myopia, suggesting no
evidence for Sco2 mutations causing high myopia. However, as
only SCO2 gene mutations have been reported in families
showing dominantly inherited disease, affected individuals in
this study were also examined for SCO2 variants by exome and
Sanger sequencing, but no potentially pathogenic mutations
were identified.
To date, more than 60 common SNPs implicating loci for
myopia/refractive error have been identified through
GWAS.12,13 We examined the gene nearest to each associated
SNP for variants in our high myopia cohort (Supplementary
Table S1). However, no potentially pathogenic variants were
identified within these genes in our exome data. While over
6000 significant SNP-trait associations have been reported
through GWAS,51 these studies were designed to detect
associations between common variants in the population and
common diseases. Several ophthalmic GWAS have uncovered
loci that may help identify molecular pathways associated with
ocular diseases such as age-related macular degeneration and
glaucoma.52 However, for the study of less common diseases
such as high myopia, it is possible that many loci still remain
unidentified.53,54 Furthermore, approximately 80% of trait-
associated SNPs reported are located in intergenic or
noncoding regions,55 raising additional questions about our
current understanding of gene regulation in disease pheno-
TABLE 4. Novel Variants Identified in Families With High Myopia
Gene Position Transcript
Nucleotide
Change
Residue
Change Type of Variant
Conser-
vation FATHMM SIFT Family
AKAP12 6:151671097 NM_005100.3 c.1571G>A p.Gly524Asp Nonsynonymous 7.823 Tolerated Tolerated 111
ANPEP 15:90349571 NM_001150.2 c.244C>G p.Pro82Ala Nonsynonymous 9.721 Tolerated Damaging 110
ARFGEF2 20:47606168 NM_006420.2 c.2761T>A p.Cys921Ser Nonsynonymous 7.997 Tolerated Damaging 104
ATL3 11:63396862 NM_015459.3 c.1555G>A p.Gly519Ser Nonsynonymous 0.134 Damaging Tolerated 122
CAPN8 1:223718199 NM_001143962.1 c.1547A>G p.Glu516Gly Nonsynonymous 2.213 Damaging Damaging 122
CEP128 14:81372334 NM_152446.3 c.326T>G p.Leu109Trp Nonsynonymous 6.05 Tolerated Damaging 115
CPD 17:28750626 NM_001304.4 c.1760C>A p.Thr587Lys Nonsynonymous 1.47 Tolerated Tolerated 101
CSNK2B 6:31637201 NM_001320.5 c.473A>G p.Tyr158Cys Nonsynonymous 8.553 N/A Damaging 111
DNAH12 3:57391521 NM_178504.4 c.6378G>C p.Glu2126Asp Nonsynonymous 0.253 Tolerated Damaging 104
EXOC7 17:74099470 NM_001145297.2 c.98A>G p.Glu33Gly Nonsynonymous 5.844 N/A Tolerated 104
FBXO31 16:87417206 NM_024735.3 c.145G>A p.Gly49Arg Nonsynonymous 2.817 N/A Tolerated 104
HOXA2* 7:27142079 NM_006735.3 c.41G>C p.Ser14Thr Nonsynonymous 7.415 Tolerated Damaging 155
IBTK 6:82935292 NM_015525.2 c.727G>T p.Val243Leu Nonsynonymous 3.594 Damaging Tolerated 130
IL31RA 5:55206426 NM_139017.5 c.1568T>C p.Ile523Thr Nonsynonymous 0.258 Tolerated Tolerated 155
KIAA1324 1:109743448 NM_001267048.1 c.2638G>A p.Glu880Lys Nonsynonymous 9.732 Tolerated Damaging 122
KLHDC8B 3:49212244 NM_173546.2 c.611G>A p.Arg204Gln Nonsynonymous 7.868 Tolerated Tolerated 155
KMT2A 11:118374678 NM_001197104.1 c.8071G>A p.Val2691Met Nonsynonymous 5.921 Damaging Tolerated 122
MAML2,
MIR1260B
11:96074606 NM_032427.1 c.454G>A p.Gly152Arg Nonsynonymous 2.428 Tolerated Tolerated 115
MGRN1 16:4707316 NM_001142289.2 c.513C>G p.Phe171Leu Nonsynonymous 3.969 Tolerated Damaging 104
MICU2 13:22178157 NM_152726.2 c.131T>C p.Leu44Pro Nonsynonymous 3.572 Tolerated Tolerated 122
NR3C1 5:142678245 NM_001024094.1 c.1883T>G p.Leu628Arg Nonsynonymous 9.339 Damaging Damaging 110
ODF2L 1:86841964 NM_001184765.1 c.762_763insA p.His255fs Frameshift insertion N/A N/A N/A 122
PROSER2,
PROSER2-AS1
10:11911987 NM_153256.3 c.890C>G p.Pro297Arg Nonsynonymous 0.212 Tolerated Damaging 115
PYROXD1 12:21614986 NM_024854.3 c.925G>A p.Gly309Ser Nonsynonymous 9.447 N/A Tolerated 104
RALGPS1,
ANGPTL2
9:129870361 NM_012098.2 c.650C>T p.Pro217Leu Nonsynonymous 8.674 Tolerated Tolerated 111
SORBS3 8:22426677 NM_005775.4 c.1322A>G p.Glu441Gly Nonsynonymous 5.807 Tolerated Damaging 111
SPAG17 1:118642247 NM_206996.2 c.811G>C p.Val271Leu Nonsynonymous 0.311 Tolerated Tolerated 155
TMPO* 12:98925463 NM_003276.2 c.412A>G p.Thr138Ala Nonsynonymous 7.895 Damaging Damaging 111
TRMT44 4:8442843 NM_152544 c.294C>A p.Cys98Ter Stopgain 0.038 N/A Tolerated 104
UPK2 11:118827653 NM_006760.3 c.136_137insT p.Ala47fs Frameshift insertion N/A N/A N/A 122
USPL1 13:31233351 NM_005800.4 c.3137C>T p.Ala1046Val Nonsynonymous 0.735 Tolerated Tolerated 122
Chromosome position in accordance with GRCh37/hg19 assembly. Conservation is scored by PhyloP 100-way Vertebrate, in which sites
predicted to be conserved are assigned positive scores.
* Variant is both novel and located within MYP locus.
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types. Another consideration is that the age at which GWAS-
identified variants may contribute to myopia in the global
population is not known. Fan et al.56 examined the age-of-onset
correlation between refractive error and GWAS-identified
variants in 5200 children examined longitudinally from ages
7 to 15 years, and found many differences between specific
SNPs and their effects during very early life, childhood, or
adulthood. Some SNPs showed progressively stronger effects
during later childhood while others appeared to have no
progressive effect on refractive error. This study also examined
the effects of gene-environment interactions involving near
work or time spent outdoors, but these associations were rare
or absent for most of the GWAS-identified SNPs.
To investigate the variation in our cohort within loci linked
to refractive error, the 23 MYP loci were examined. In our
exome data, 10 variants were identified within these coordi-
nates, two of which are novel (Table 3). Three variants, in
genes PTPRQ, TMPO, and TMTC2, were identified at the MYP3
locus, which was mapped to chromosome 12q21-q23 in a large
German/Italian family segregating autosomal dominant high
myopia.17 Variants in PTPRQ and TMTC2 were identified in
family 115, and the variant in TMPO was identified in family
111. PTPRQ encodes a protein-tyrosine phosphatase implicat-
ed in autosomal recessive deafness.57 A heterozygous missense
change in Thymopoietin (TMPO) was identified in two
brothers with a severe form of cardiomyopathy.58 The variant
identified in TMPO in this study was novel. In 2015, a meta-
analysis of genome-wide association performed by the Inter-
national Glaucoma Genetics Consortium identified a SNP near
the gene transmembrane and tetratricopeptide repeat contain-
ing 2 (TMTC2) associated with optic disc morphology and
glaucoma,59 which may indicate a possible role for TMTC2 in
the eye.
In family 104, one variant in the gene ETNPPL (alanine-
glyoxylate aminotransferase 2-like 1 [AGXT2L1]) was identified
in MYP11, which was mapped to chromosome 4 in a large
Chinese family with autosomal dominant high myopia.22 The
gene ETNPPL encodes for the protein AGXT2L1.
Two variants were identified at MYP14 (chromosome 1p26)
which was mapped using 49 multigenerational Ashkenazi
Jewish families with high myopia.26 These two variants are
nonsynonymous changes in the genes AGRN and PLOD1
identified in families 130 and 122, respectively. Agrin (AGRN)
plays a role in synapse formation and brain development. A
homozygous mutation in AGRN was reported in a Swiss
brother and sister with congenital myasthenia syndrome
(CMS8) which affects skeletal muscle and neuromuscular
junctions,60 while compound heterozygosity for two mutations
in AGRN was identified in another individual with CMS8.61
Homozygous mutations in the collagen-modifying gene PLOD1
have been implicated in Ehlers-Danlos syndrome, a heritable
connective tissue disorder that includes several ocular
manifestations including myopia (OMIM 153454).49,62 Com-
mon SNPs in PLOD1 were also studied in a cohort of 600
unrelated Chinese Han individuals (300 with high myopia), but
were determined unlikely to result in genetic susceptibility for
high myopia.63
Originally, MYP4 was mapped to chromosome 7q36 after
linkage analysis was performed in 21 French and 2 Algerian
families with autosomal dominant high myopia.64 However, a
second study using the same families along with nine newly
collected families failed to confirm linkage to 7q36, but rather
to 7p15 and the MYP4 locus was renamed MYP17.29 A study
performed by Ciner et al.30 in the same year also identified
linkage to chromosome 7p15 after performing quantitative trait
locus linkage analyses in 493 African American individuals and
in 96 African American families. In our study, nonsynonymous
variants were identified at the MYP17/4 locus in genes
DNAH11 and HOXA2. Mutations in the dynein gene DNAH11
have been reported in Kartagener syndrome, a type of ciliary
dyskinesia in which patients suffer from chronic respiratory
infections, recurrent bronchitis, and pneumonia.65,66 Homeo-
box A2 (HOXA2) mutations have been implicated in autosomal
dominant and recessive forms of microtia and hearing
impairment, sometimes accompanying cleft palate.67,68 In this
study, the variant identified in HOXA2 was novel.
Two variants in the genes essential meiotic structure-
specific endonuclease 1 (EME1) and transducer of ERBB2 1
(TOB1) were identified at the MYP5 locus, which was mapped
to chromosome 17q21-q22 in a multigenerational English/
Canadian family with autosomal dominant high myopia.18
However, no causal mutation was reported in that publication.
The same family was utilized for this study (family 68), and
notably the proband of family 68 had the most severe SE
refractive error (50.00/50.00 D) of our cohort. Exome data
from three affected and one unaffected individuals were
filtered for potentially pathogenic variants. Two variants were
identified; one variant identified in the gene FtsJ Homolog 3
(FTSJ3) encodes a missense change, while a variant identified
in the gene Solute Carrier Family 7 Member 13 (SLC7A13)
results in a premature stop codon in the third of four exons
(Supplementary Table S2). Neither of these variants were
located within the MYP5 locus previously linked to this family
or within any other MYP loci.
A second large family in our cohort has also undergone
prior linkage analysis. Family 56, a Caucasian family from the
United States, is a large autosomal dominant high myopia
family in which nearly half of the individuals are highly myopic.
A novel locus at chromosome 2q37.1 (MYP12) was deter-
mined, but causal mutations were not identified.23 To identify
candidate causative variants in this family, we performed
exome sequencing on 11 individuals, including 8 that were
affected. However, no variants were identified that were
present in all 8 affected individuals sequenced. It is interesting
to note that within both families 56 and 68, no variants that
met our filtering criteria were identified within the chromo-
somal regions where linkage studies previously mapped
myopia-associated loci. While genetic linkage analysis is a
powerful tool for mapping disease loci in Mendelian disorders
in families, there are limitations. Since proper linkage requires
a large family with multiple generations demonstrating the
phenotype, most of our families were too small to evaluate
using this method. Genetic linkage studies are less helpful for
multifactorial or complex traits, where multiple genes are
important in disease causation. However, given its severity in
young children and infants, and the clearly Mendelian
inheritance pattern, there are likely to be strong genetic
determinants in high myopia. Nevertheless, myopia is a highly
variable disease, with refractive measurements varying greatly
between affected individuals in the same family as well as
between eyes of the same individual. Numerous studies have
examined the correlation between environmental factors and
myopia, including levels of education, increased near work,
rural versus urban settings, diet, and outdoor activities.69 A
combination of genetic susceptibility and environmental
triggers may play a role together in disease manifestation and
progression.
Notably for this study, potentially pathogenic variants
cosegregating with high myopia were only identified in 10 of
14 families in our cohort. No variants meeting our filtering
criteria were identified in families 8, 19, 56, 126. In addition to
the added complications given the variability in myopia
severity, there are also limitations using exome sequencing as
a method to detect causal variants. It was previously estimated
that approximately 85% of disease-causing mutations are found
in the coding regions of the genome,70 but our understanding
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of the noncoding region’s importance has recently rapidly
evolved. The protein-coding exome comprises approximately
2% of the human genome, and as functional consequences can
occur in response to sequence variation outside of coding
regions, whole-genome sequencing may resolve the underlying
molecular etiology. Furthermore, exome sequencing is unable
to reliably detect large insertions, deletions, or rearrangements,
and errors in calling small indel variants are common. Exome
capture kits offered by companies such as Agilent or Roche
NimbleGen are dependent on our knowledge of the expressed
regions of the human genome, and therefore exclude variants
in regions of the genome that are not currently known to be
transcribed. Exome coverage is also incomplete, with less than
80% of the exome captured at more than 320 coverage with
the Agilent platform (SureSelect) that was utilized for the most
recent exome sequencing performed in this study,69,71 though
some groups have reported up to 95% coverage of RefSeq
coding exons in their exome data.72,73 Another potential
source of error is the possibility of healthy control populations
having unreported high myopia. Many do not consider high
myopia a disease and may underestimate their roles as controls
in genetic studies. It is therefore difficult to be certain that
genomic databases are free of highly myopic individuals when
making conclusions in our studies.
While whole genome sequencing remains cost prohibitive
for many research groups, it offers advantages over exome
sequencing when the pathogenic mutation is suspected to be
located in a noncoding region. Variations in upstream elements
such as promoters, enhancers, and silencers may be assessed
for potential regulatory impact. Noncoding regions that show
high conservation among different species as well as predicted
transcription factor binding sites can be analyzed for variations.
Sequence capture kits are also expected to offer expanded
targets in the future which may help to identify variations in
noncoding DNA. Advancements in complex prediction algo-
rithms may also aid in the assessment of potentially pathogenic
gene variants.
In conclusion, we have identified 104 new candidate
variants for high myopia. These variants will require future
study in additional patient subjects with high myopia,
functional analyses, and/or animal modeling in order to
determine their role in this phenotype.
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